Government ❯Regulatory Agencies ❯FDA

Vaccine Approval

Public Health Policy Panel Decisions Age Expansion COVID-19

FDA Expands Approval of GSK's RSV Vaccine to Adults Aged 50-59

FDA Advisers Recommend JN.1-Based COVID Vaccine for Fall

FDA Approves Moderna's mRNA RSV Vaccine for Older Adults